Clinical trial
Evaluating the Feasibility and Acceptability of Expectation-optimized Open-label Placebo as an Adjuvant Treatment for Chronic Pain
NCT07735520 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Feasibility and Acceptability of Expectation-optimized Open-label Placebo as an Adjuvant Treatment for Chronic Pain
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- July 1, 2027
- Completion date
- December 31, 2029
- Enrollment
- 57 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
temporomandibular disorders (tmd)